MarketPeel
Insider Trading Intelligence
JA

June Sherie Almenoff

ATNM
DIRECTOR · ACTINIUM PHARMACEUTICALS, INC. · CIK 0001492647
FILING MIX · LIFETIME93%/7%
BUYS
26
SELLS
2
TOTAL VALUE
$42.6K
COMPANIES
3
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
50,100
AVG SELL PX
TRADE KIND
SHOWING 28 / 28
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 6 pending
Forward-return performance of every backtestable P/S trade by June Sherie Almenoff, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+3.09%+0.12%+2.97%+3.71%
14d4+50.00%-2.53%+1.59%-4.11%-4.33%
30d4+50.00%+16.81%+1.44%+15.37%+14.71%
60d4+50.00%+33.28%+0.99%+32.30%+30.57%
90d4+50.00%+13.45%+2.31%+11.14%+9.71%
180d4+50.00%-4.15%+5.13%-9.27%-10.97%
1y4(2 pending)+100.00%+15.19%+14.24%+0.95%+0.95%
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ATNM · 0 shares · as of Mar 31, 2025
012,50025,00037,50050,0002025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 26 buys / 2 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TENX
TENAX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Jan 9, 2026Jan 13, 2026View →
TENX
TENAX THERAPEUTICS, INC.
PURCHASE
1,900$7.52$14.3K1,993Nov 18, 2025Nov 19, 2025View →
TENX
TENAX THERAPEUTICS, INC.
PURCHASE
1,900$7.52$14.3K1,993Nov 18, 2025Nov 20, 2025View →
TENX
TENAX THERAPEUTICS, INC.
PURCHASE
93$7.15$66593Nov 17, 2025Nov 19, 2025View →
TENX
TENAX THERAPEUTICS, INC.
PURCHASE
93$7.15$66593Nov 17, 2025Nov 20, 2025View →
TENX
TENAX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,00080,000Jul 1, 2025Jul 3, 2025View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,10020,100Jun 17, 2025Jun 18, 2025View →
ATNM
ACTINIUM PHARMACEUTICALS, INC.
SALE
50,0000Mar 31, 2025Apr 2, 2025View →
AVTX
AVALO THERAPEUTICS, INC.
SALE
3,1676,333Mar 28, 2025Apr 1, 2025View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
3,1673,167Mar 28, 2025Apr 1, 2025View →
TENX
TENAX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,000100,000Dec 10, 2024Dec 12, 2024View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
500$13.00$6.5K1,000Nov 13, 2024Nov 14, 2024View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASE
500$12.50$6.2K500Nov 12, 2024Nov 14, 2024View →
ATNM
ACTINIUM PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
50,00050,000Nov 1, 2024Nov 5, 2024View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,60024,600Aug 13, 2024Aug 14, 2024View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,5009,500Aug 13, 2024Aug 14, 2024View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,3343,334Dec 20, 2023Dec 21, 2023View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,5754,575Jun 30, 2023Jul 5, 2023View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
1,1671,167Mar 31, 2023Apr 4, 2023View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
410410Dec 30, 2022Jan 3, 2023View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
605605Sep 30, 2022Oct 3, 2022View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,3384,338Jun 30, 2022Jul 1, 2022View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jun 14, 2022Jun 15, 2022View →
TENX
TENAX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,0005,000Jun 9, 2022Jun 10, 2022View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,9852,985Mar 31, 2022Apr 4, 2022View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
737737Dec 31, 2021Jan 4, 2022View →
AVTX
AVALO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,00080,000Nov 10, 2021Nov 12, 2021View →
TENX
TENAX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,2506,250Jun 10, 2021Jun 15, 2021View →
Other insiders · ATNM
Loading peer insiders…
About this filer
CIK 0001492647
ROLE
Director
PRIMARY
ATNM
COMPANIES
3
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001492647DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback